Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201304065 Principal Investigator: Carson, Kenneth
Title: A Phase 3, Randomized, Two-Arm, Open-Label, Multicenter, International Trial of Alisertib (MLN8237) or Investigator’s Choice (Selected Single Agent) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Phase: III Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The main purpose of this trial is to assess the anti-cancer activity of alisertib (an investigational drug) as compared to other standard treatments for patients with Peripheral T-Cell Lymphoma.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)